Biotechnology Assets S.A. (BST) — Free Cash Flow Generation Index
Biotechnology Assets S.A. (BST) has a Free Cash Flow Generation Index of 1.00x as of June 2025. Free cash flow of €656.15K represents 1% of operating cash flow (€658.13K). Explore Biotechnology Assets S.A. capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Biotechnology Assets S.A. Free Cash Flow Generation Index (2015–2023)
Historical FCF Generation Index trend for Biotechnology Assets S.A. across 5 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Biotechnology Assets S.A..
Annual Free Cash Flow Generation for Biotechnology Assets S.A. (2015–2023)
Year-by-year Free Cash Flow Generation Index for Biotechnology Assets S.A.. Check BST cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | -5.83x | €-278.23K | €47.74K | €325.97K | ▼ -710.0% |
| 2020 | 0.96x | €8.40 Million | €8.79 Million | €391.53K | ▲ +115.1% |
| 2017 | -6.33x | €-1.35 Million | €213.49K | €1.56 Million | ▼ -2994.9% |
| 2016 | -0.20x | €-555.22K | €2.71 Million | €3.27 Million | ▲ +96.4% |
| 2015 | -5.75x | €-910.02K | €158.16K | €1.07 Million | — |